|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61K 31/198 | (2013.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 25/04 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3598971 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19196366.9 |
| Date of filing the European patent application | 2014-01-22 | |
| (97) | Date of publication of the European application | 2020-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361849191 P | 2013-01-22 | US |
| (72) |
Snodgrass, Ralph H. , US
Cato, Allen E. , US
Hicklin, Jack S. , US
|
| (73) |
Vistagen Therapeutics, Inc. ,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |